Small-cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview.
Pooya SaraieAbbas HeshmatiSare HosseiniPublished in: Journal of neuroendocrinology (2024)
Small-cell neuroendocrine carcinomas (SCNECs) of the female genital tract are rare and aggressive tumors that are characterized by a high rate of recurrence and poor prognosis. They can arise from various sites within the female genital tract, including the cervix, endometrium, ovary, fallopian tube, vagina, and vulva. They are composed of cells with neuroendocrine features, such as the ability to produce and secrete hormones and peptides, and a high mitotic rate. Immunohistochemical staining for neuroendocrine markers, such as chromogranin A, synaptophysin, and CD56, can aid in the diagnosis of these tumors. This article provides an overview of the epidemiology, etiology, and risk factors associated with these tumors, as well as their clinical presentation, cellular characteristics, diagnosis, and finally the current treatment options for SCNECs, including surgery, chemotherapy, and radiation therapy, alone or in combination.
Keyphrases
- poor prognosis
- radiation therapy
- long non coding rna
- single cell
- cell therapy
- induced apoptosis
- locally advanced
- cell cycle arrest
- stem cells
- coronary artery bypass
- risk factors
- cell cycle
- mesenchymal stem cells
- coronary artery disease
- rectal cancer
- oxidative stress
- radiation induced
- signaling pathway
- endoplasmic reticulum stress